John Glenn's Net Worth

$1.76 Million

Estimate Recalculated Apr 4, 2024 08:54PM EST

Who is John Glenn?

John Glenn has an estimated net worth of $1.76 Million. This is based on reported shares across multiple companies, which include EKSO BIONICS HOLDINGS, INC., IRADIMED CORP, SOLTA MEDICAL INC, CHOLESTECH CORPORATION, and INVIVO CORP.

SEC CIK

John Glenn's CIK is 0001253497

Past Insider Trading and Trends

2022 was John Glenn's most active year for acquiring shares with 6 total transactions. John Glenn's most active month to acquire stocks was the month of January. 2004 was John Glenn's most active year for disposing of shares, totalling 8 transactions. John Glenn's most active month to dispose stocks was the month of December. 2022 saw John Glenn paying a total of $71,675.75 for 61,310.183 shares, this is the most they've acquired in one year. In 2014 John Glenn cashed out on 735,075 shares for a total of $1,551,825.48, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

EKSO BIONICS HOLDINGS, INC. (EKSO) Snapshot price: $2.13

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-8.97%
-3.46K
$2.82
-$9,761.80
35.13K
Mar 22
Form 4
+60.83%
14.6K
—
—
38.59K
Feb 17
Form 4
+118.52%
13.02K
—
—
24K
Mar 3
Form 4
+3,397.13%
10.67K
—
—
10.98K
Apr 1
Form 4
—
0
—
—
0
Nov 6
Form 4
-68.61%
-10.29K
$1.37
-$14,100.04
4.71K
May 31
Form 4
∞
15K
—
—
15K
Apr 24
Form 4
—
0
—
—
0
Aug 31
Form 3
—
0
—
—
0
No matching records found

IRADIMED CORP (IRMD) Snapshot price: $45.77

CHIEF FINANCIAL OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 7
Form 4
+175.32%
4.38K
$47.88
-$67,606.56
6.88K
Jun 20
Form 4
∞
2.5K
$28.67
$71,675.75
2.5K
Dec 15
Form 4
—
0
—
—
0
Dec 7
Form 4/A
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 20
Form 3
—
0
—
—
0
No matching records found

SOLTA MEDICAL INC No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-89.05%
-337.96K
$2.92
-$1,108,195.48
41.56K
Jan 23
Form 4
+8.54%
26.05K
$2.56
-$137,072.64
331.16K
Feb 8 - Feb 10
Form 4
+43.17%
92K
—
—
305.11K
Feb 4
Form 4
+3.61%
7.28K
$2.99
-$63,994.97
208.72K
Feb 9 - Feb 10
Form 4
+85.76%
93K
—
—
201.44K
Feb 8
Form 4
+455.06%
85.2K
—
—
103.92K
Feb 10
Form 4
—
0
—
—
0
Feb 8
Form 4
-33.60%
-7.66K
$2.00
-$15,312.00
15.13K
Jan 23
Form 4
—
0
—
—
0
Feb 27
Form 4
∞
17.79K
—
—
17.79K
Dec 23
Form 4
—
0
—
—
0
Feb 11
Form 3
—
0
—
—
0
No matching records found

CHOLESTECH CORPORATION No price found

CFO and V.P. Finance

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-3.00K
—
—
0
Sep 12
Form 4
—
0
$12.30
-$53,314.00
3K
Nov 15
Form 4
—
0
—
—
0
Mar 22
Form 4
—
0
—
—
0
Mar 23
Form 4
+50.00%
1K
$10.90
$10,900.00
3K
Mar 3
Form 4
∞
2K
$8.01
$16,020.00
2K
Nov 8
Form 4
—
0
—
—
0
Oct 13
Form 3
—
0
—
—
0
No matching records found

INVIVO CORP No price found

CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 30
No matching records found